Circular Genomics Receives $250K Investment from the Alzheimer's Drug Discovery Foundation (ADDF) to Advance First-in-Class Circular RNA Blood-Based Biomarker Tests for the Early Detection of AD

Press releases

Jul 8

Circular Genomics Announces Formation of its Commercial Advisory Board with Veteran Industry Leaders

Press releases

Jun 18

Circular Genomics Strengthens Scientific Advisory Board with Addition of Alzheimer's Disease Expert

Press releases

Mar 19